BioRestorative Therapies Inc reports results for the quarter ended March 31 - Earnings Summary

Biorestorative Therapies

15/05/2025 20:25

BioRestorative Therapies Inc BRTX.OQ reported a quarterly adjusted loss of 64 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -33 cents.  The mean expectation of two analysts for the quarter was for a loss of 32 cents per share. Wall Street expected results to range from -33 cents to -32 cents per share.

Revenue fell 28.6% to $25.00 thousand from a year ago; analysts expected $380.00 thousand.

BioRestorative Therapies Inc's reported EPS for the quarter was a loss of 64 cents​.

The company reported a quarterly loss of $5.34 million.

BioRestorative Therapies Inc shares had fallen by 3.9% this quarter and gained 19.6% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 25% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for BioRestorative Therapies Inc is $13.00

This summary was machine generated from LSEG data May 15 at 07:24 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.32
-0.64
Missed
Dec. 31 2024
-0.27
-0.20
Beat
Sep. 30 2024
-0.43
-0.13
Beat
Jun. 30 2024
-0.56
-0.50
Beat